BackLeanLife Health Overview

LeanLife Health EBIT

LeanLife Health's EBIT is $-3.2M, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$663.16K
↑ 55.52% YoY

As of Dec 31, 2021

Annual EBIT (TTM)

-$3.25M
↑ 14.44% YoY

Trailing 12 months ending Dec 31, 2021

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

LeanLife Health (LNLHF) FAQ

The latest EBIT for LNLHF is $-3.2M as of December 2021. That compares with $-3.8M in the prior-year period — up 14.4% year over year. That is below the sector sector average of $2.4T. Investors often review this figure alongside LeanLife Health's historical trend and sector peers before judging valuation or financial health.

Over the past year, LNLHF's EBIT moved from $-3.8M to $-3.2M — a 14.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in LeanLife Health's operating scale or balance-sheet position.

Against its sector companies, LNLHF currently prints $-3.2M for EBIT, while the sector average sits near $2.4T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at LeanLife Health's growth, margins, and balance sheet.

A EBIT figure of $-3.2M for LNLHF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.4T. Explore the charts below for those layers of context.

After noting LNLHF's EBIT ($-3.2M), review year-over-year change from $-3.8M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers